Related Experiment Videos
[Tumor angiogenesis and tumor angiogenesis inhibitors]
1Dept. of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|June 1, 2001
Abstract:
It is important to survey the molecular targets which are involved in tumor angiogenesis for the development of antiangiogenic agents as one of the cancer therapy. This article is meant to review the recent molecular targets of tumor angiogenesis and the molecular mechanism of antiangiogenic agents in human clinical trials.
Insights
Identifying molecular targets in tumor angiogenesis is key for developing effective cancer therapies. This review covers recent targets and antiangiogenic agent mechanisms in clinical trials.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Tumor angiogenesis is crucial for cancer growth and metastasis.
- Antiangiogenic agents target the process of new blood vessel formation in tumors.
- Understanding molecular targets is essential for developing novel cancer treatments.
Purpose of the Study:
- To review recent molecular targets involved in tumor angiogenesis.
- To discuss the mechanisms of antiangiogenic agents currently in human clinical trials.
Main Methods:
- Literature review of recent studies on tumor angiogenesis.
- Analysis of molecular targets and antiangiogenic agents in clinical trials.
Main Results:
- Identification of key molecular targets in tumor angiogenesis.
- Overview of the efficacy and mechanisms of various antiangiogenic agents.
Conclusions:
- Targeting tumor angiogenesis is a promising strategy in cancer therapy.
- Further research into molecular targets and agent mechanisms will advance antiangiogenic drug development.